Global Intragastric Balloon Market: Drivers, Opportunities, Trends and Forecast 2017-2023
Global Intragastric Balloon Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Gastric balloon is a medical device that is used in an endoscopic intragastrical procedure, where the inflated silicone balloon is inserted in the stomach and is retained there for 6–12 months. This is widely known as weight loss balloon that is designed to help individuals to eat less and feel full sooner while eating. This makes less room for food and helps the body to adapt to healthy portions. This procedure is non-surgical, non-invasive, and requires no-incision. However, this procedure is not permanent and helps individual to lose up to three times the weight when compared to diet alone. Apart from weight loss it has many health benefits as it helps in improving diabetes, maintains cardiac health, and improves other bone-related issues.
Endoscopic bariatric therapies (EBT) have shown greater results and less adverse events. The delivery of EBT requires special room facility and preparation that will accommodate the size, weight, and surgical gowns for the patient.
The FDA approved products, such as Orbera intragastric balloon, the AspireAssist, and ReShape Integrated Dual Balloon have high signifiance in the market.
Intragastric balloon offers non-surgical and less invasive endoscopic procedure with reversible weight measurement that has grown in a scale with stronger impact on the market. Therefore, as more EBT are available for obese patients it will become more feasible and effective to offer long-term treatment in the future.
The major products in the market include:
Market Analysis: The Global Intragastric Balloon Market is estimated to witness a CAGR of 9.6% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product type, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). The Americas is set to be the leading region for the intragastric balloon market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the number of obese population and its related chronic disorders. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of diseases. Medical tourism is the new trend in emerging markets as most of the people from developed countries are traveling to APAC, especially India, for bariatric procedures. However, the high cost of intragastric balloons and expensive procedural costs, lack of skilled surgeons, lack of proper reimbursement policies, lack of awareness about gastric balloons in developed and developing countries have significant impact on the overall market growth.
Product Analysis: Single intragastric balloon is growing at a steady rate and dominates the global intragastric balloon market with 55% of the total market share. Factors, such as the increasing obese population, rise in prevalence of chronic diseases, and rise in popularity of minimally non-invasive techniques, are driving the market growth. The is one of the first and well-known gastric balloon used since the introduction of intragastric balloons in the market. The popularity of single intragastric balloon for its non-invasive technique and alternative to undergo the knife has increased the adoption of gastric balloons in the market accounting for 50% of the total market share. Orbera by Apollo Endosurgery is one of the most popular single gastric balloon that received FDA clearance in August 2015. This product is also known as BIB (BioEnterics Intragastric Balloon). It is made of silicone and filled with saline after endoscopic transoral placement inside the patient’s stomach.
Key Players: Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and other predominant & niche players.
Competitive Analysis: The global intragastric balloon market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of gastric balloons, especially in the US, Canada, France, Germany, and the UK and few of the Middle East Countries. These countries have the highest obese population accounting to 70% to 75% of the total obese population worldwide. Major vendors are directly competing with primary bariatric invasive surgical companies for replacing surgeries such as sleeve gastrectomy, gastric bypass, and various laparoscopy surgeries. Most of the companies, including tier II companies also focus on building a strong relationship with the customers and physicians to have direct sales and product revenue generation. The growing awareness about the products and rise in number of physician-owned implant distributions that have resulted in the rise in volume of intragastric balloon procedures have led individuals undergo treatment for obesity.
Benefits: The report provides complete details about the usage and adoption rate of intragastric balloons for the treatment of obesity. Therefore, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the intragastric balloon adoption in the upcoming years. They can also get details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview: Gastric balloon is a medical device that is used in an endoscopic intragastrical procedure, where the inflated silicone balloon is inserted in the stomach and is retained there for 6–12 months. This is widely known as weight loss balloon that is designed to help individuals to eat less and feel full sooner while eating. This makes less room for food and helps the body to adapt to healthy portions. This procedure is non-surgical, non-invasive, and requires no-incision. However, this procedure is not permanent and helps individual to lose up to three times the weight when compared to diet alone. Apart from weight loss it has many health benefits as it helps in improving diabetes, maintains cardiac health, and improves other bone-related issues.
Endoscopic bariatric therapies (EBT) have shown greater results and less adverse events. The delivery of EBT requires special room facility and preparation that will accommodate the size, weight, and surgical gowns for the patient.
The FDA approved products, such as Orbera intragastric balloon, the AspireAssist, and ReShape Integrated Dual Balloon have high signifiance in the market.
Intragastric balloon offers non-surgical and less invasive endoscopic procedure with reversible weight measurement that has grown in a scale with stronger impact on the market. Therefore, as more EBT are available for obese patients it will become more feasible and effective to offer long-term treatment in the future.
The major products in the market include:
- Orbera
- Spatz Adjustable Balloon system
- ReShape Duo Integrated DualBalloon System
- The Elipse
- Air-supplied Obalon Gastric Balloon
- Heliosphere BAG
Market Analysis: The Global Intragastric Balloon Market is estimated to witness a CAGR of 9.6% during the forecast period 2017–2023. The market is analyzed based on three segments, namely product type, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). The Americas is set to be the leading region for the intragastric balloon market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the number of obese population and its related chronic disorders. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of diseases. Medical tourism is the new trend in emerging markets as most of the people from developed countries are traveling to APAC, especially India, for bariatric procedures. However, the high cost of intragastric balloons and expensive procedural costs, lack of skilled surgeons, lack of proper reimbursement policies, lack of awareness about gastric balloons in developed and developing countries have significant impact on the overall market growth.
Product Analysis: Single intragastric balloon is growing at a steady rate and dominates the global intragastric balloon market with 55% of the total market share. Factors, such as the increasing obese population, rise in prevalence of chronic diseases, and rise in popularity of minimally non-invasive techniques, are driving the market growth. The is one of the first and well-known gastric balloon used since the introduction of intragastric balloons in the market. The popularity of single intragastric balloon for its non-invasive technique and alternative to undergo the knife has increased the adoption of gastric balloons in the market accounting for 50% of the total market share. Orbera by Apollo Endosurgery is one of the most popular single gastric balloon that received FDA clearance in August 2015. This product is also known as BIB (BioEnterics Intragastric Balloon). It is made of silicone and filled with saline after endoscopic transoral placement inside the patient’s stomach.
Key Players: Apollo Endosurgery, Spatz FGIA, ReShape Medical, and Obalon Therapeutics, and other predominant & niche players.
Competitive Analysis: The global intragastric balloon market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of gastric balloons, especially in the US, Canada, France, Germany, and the UK and few of the Middle East Countries. These countries have the highest obese population accounting to 70% to 75% of the total obese population worldwide. Major vendors are directly competing with primary bariatric invasive surgical companies for replacing surgeries such as sleeve gastrectomy, gastric bypass, and various laparoscopy surgeries. Most of the companies, including tier II companies also focus on building a strong relationship with the customers and physicians to have direct sales and product revenue generation. The growing awareness about the products and rise in number of physician-owned implant distributions that have resulted in the rise in volume of intragastric balloon procedures have led individuals undergo treatment for obesity.
Benefits: The report provides complete details about the usage and adoption rate of intragastric balloons for the treatment of obesity. Therefore, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the intragastric balloon adoption in the upcoming years. They can also get details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Emerging Global Markets
1.3 Weight related disorders
1.4 Industry Trends
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.2.1 Definition
3.2.2 Importance of intragastric balloon
3.2.3 Single Intragastric Balloon
3.2.4 Dual Intragastric Balloon
3.2.5 Triple Intragastric Balloon
3.3 Related Markets
3.3.1 Breast Implant Market
3.3.2 Dental Implant Market
3.3.3 Facial Implant Market
4 MARKET OUTLOOK
4.1 Overview
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 DRO – Global Intragastric Balloon Market Dynamics
5.2.1 Drivers
5.2.1.1 Rise in the prevalence of obesity
5.2.1.2 Increase prevalence of chronic diseases
5.2.1.1 Increasing popularity of MI techniques
5.2.1.2 Increase in number of outpatient procedure
5.2.2 Opportunities
5.2.2.1 Emerging endo-bariatric technology for treating obesity
5.2.2.1 Increase healthcare spending
5.2.2.2 Rise in medical tourism
5.2.3 Restraints
5.2.3.1 High cost of intragastric balloon procedures
5.2.3.2 Alternative techniques for treatment of obesity
5.2.3.3 Complications and risk associated with spine surgeries
5.2.3.4 Stringent regulatory framework and labeling requirement
5.2.3.5 Poor reimbursement policies
5.2.3.6 Intense competition among vendors
5.2.4 DRO – Impact Analysis
5.2.5 Key Stakeholders
6 TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Single Intragastric Balloon
6.2.1 Overview
6.3 Dual Intragastric Balloon
6.3.1 Overview
6.4 Triple Intragastric Balloon
6.4.1 Overview
7 END USER: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Bariatric Surgical Centers
7.3 Ambulatory Surgical Care
7.4 Hospitals
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Market Overview
8.3 Europe
8.3.1 Market Overview
8.4 APAC
8.4.1 Market Overview
8.5 Rest of the World
8.5.1 Market Overview
9 COMPETITIVE LANDSCAPE
9.1 Overview
10 VENDOR PROFILES
10.1 Apollo Endosurgery, Inc.
10.1.1 Overview
10.1.2 Business Unit
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategy
10.2 OBALON THERAPEUTICS, INC.
10.2.1 Overview
10.2.2 Business Focus
10.2.3 SWOT Analysis
10.2.4 Business Strategy
10.3 Spatz FGIA, Inc.
10.3.1 Overview
10.4 ReShape Medical Inc.
10.4.1 Overview
Tables
Table 1 CATEGORIZATION OF INDIVIDUALS WITH BMI
Table 1 COMPARISON OF DIFFERENT BARIATRIC SURGERY COST IN DEVELOPED AND DEVELOPING NATIONS
Table 2 COMPARISON OF INTRAGASTRIC BALLOON PROCEDURE WITH AND WITHOUT INSURANCE IN 2016 ($)
Table 3 ALTERNATE TECHNIQUES FOR TREATMENT OF OBESITY
Table 4 GLOBAL INTRAGSTRIC BALLOON MARKET BY TYPES, 2016–2023 ($MILLION)
Table 5 GLOBAL INTRAGASTRIC BALLOON MARKET BY END-USERS
Table 6 GLOBAL INTRAGASTRIC BALLOON MARKET REVENUE BY REGIONS FORECAST, 2016–2023 ($MILLION)
Table 7 DRO (NORTH AMERICA)
Table 8 DRO (EUROPE)
Table 9 DRO (APAC)
Table 10 DRO (REST OF THE WORLD)
Table 11 APOLLO ENDOSURGERY, INC.: PRODUCT OFFERINGS
Table 12 APOLLO ENDOSURGERY, INC.: RECENT DEVELOPMENTS
Table 13 OBALON THERAPEUTICS, INC: RECENT DEVELOPMENTS
Charts
Chart 1 PERCENTAGE LOSS EXCESS WEIGHT LOSS FROM 3 MONTHS TO 1 YEAR
Chart 2 GLOBAL HEALTHCARE EXPENDITURE GDP AND PER-CAPITA SPENDING IN 2015
Chart 3 INTRAGASTRIC BALLOON DEVICES MARKET SEGMENTATION
Chart 4 RESEARCH METHODOLOGY OF GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 5 GLOBAL INTRAGASTRIC BALLOON BY SEGMENTATION, 2016 (% SHARE)
Chart 6 GLOBAL INTRAGATSRIC BALLOON MARKET SNAPSHOT 2016
Chart 7 GLOBAL INTRAGSTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 8 PEST ANALYSIS OF GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 9 PORTER 5 FORCES ON GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 10 GLOBAL INTRAGASTRIC BALLOON MARKET DYNAMIC -DRO
Chart 11 DRO – IMPACT ANALYSIS OF GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 12 KEY STAKEHOLDERS
Chart 13 GLOBAL INTRAGASTRIC BALLOON MARKET BY TYPE SEGMENTATION, 2016 (% SHARE)
Chart 14 GLOBAL INTRAGASTRIC BALLOON MARKET BY TYPE SEGMENTATION, 2023 (% SHARE)
Chart 15 GLOBAL INTRAGASTRIC BALLOON MARKET OVERVIEW BY PRODUCT TYPE 2016
Chart 16 GLOBAL SINGLE INTRAGASTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 17 GLOBAL DUAL INTRAGASTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 18 GLOBAL TRIPLE INTRAGASTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 19 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY PRODUCT TYPE, 2016-2023 ($MILLION)
Chart 20 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY PRODUCT TYPE, 2016-2023 (% SHARE)
Chart 21 GLOBAL INTRAGASTRIC BALLOON MARKET BY END-USER SEGMENTATION, 2016 (% SHARE)
Chart 22 GLOBAL INTRAGASTRIC BALLOON MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (% SHARE)
Chart 23 GLOBAL INTRAGASTRIC BALLOON MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (% SHARE)
Chart 24 GLOBAL INTRAGASTRIC BALLOON MARKET OVERVIEW BY REGIONS 2016 ($ MILLION)
Chart 25 INTRAGASTRIC BALLOON MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 26 INTRAGASTRIC BALLOON MARKET REVENUE IN THE EUROPE, 2016–2023 ($MILLION)
Chart 27 INTRAGASTRIC BALLOON MARKET REVENUE IN APAC, 2016–2023 ($MILLION)
Chart 28 INTRAGASTRIC BALLOON MARKET REVENUE IN THE REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 29 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 ($MILLION)
Chart 30 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 (% SHARE)
Chart 31 APOLLO ENDOSURGERY, INC.: OVERVIEW SNAPSHOT
Chart 32 APOLLO ENDOSURGERY, INC.: BUSINESS UNITS
Chart 33 APOLLO ENDOSURGERY, INC.: GEOGRAPHIC REVENUE
Chart 34 APOLLO ENDOSURGERY: SWOT ANALYSIS
Chart 35 OBALON THERAPEUTICS, INC.: OVERVIEW SNAPSHOT
Chart 36 OBALON THERAPEUTICS, INC.: SWOT ANALYSIS
Chart 37 SPATZ FGIA, INC.: OVERVIEW SNAPSHOT
Chart 38 RESHAPE MEDICAL INC.: OVERVIEW SNAPSHOT
1.1 Industry Overview
1.2 Emerging Global Markets
1.3 Weight related disorders
1.4 Industry Trends
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.2.1 Definition
3.2.2 Importance of intragastric balloon
3.2.3 Single Intragastric Balloon
3.2.4 Dual Intragastric Balloon
3.2.5 Triple Intragastric Balloon
3.3 Related Markets
3.3.1 Breast Implant Market
3.3.2 Dental Implant Market
3.3.3 Facial Implant Market
4 MARKET OUTLOOK
4.1 Overview
4.2 PEST Analysis
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 DRO – Global Intragastric Balloon Market Dynamics
5.2.1 Drivers
5.2.1.1 Rise in the prevalence of obesity
5.2.1.2 Increase prevalence of chronic diseases
5.2.1.1 Increasing popularity of MI techniques
5.2.1.2 Increase in number of outpatient procedure
5.2.2 Opportunities
5.2.2.1 Emerging endo-bariatric technology for treating obesity
5.2.2.1 Increase healthcare spending
5.2.2.2 Rise in medical tourism
5.2.3 Restraints
5.2.3.1 High cost of intragastric balloon procedures
5.2.3.2 Alternative techniques for treatment of obesity
5.2.3.3 Complications and risk associated with spine surgeries
5.2.3.4 Stringent regulatory framework and labeling requirement
5.2.3.5 Poor reimbursement policies
5.2.3.6 Intense competition among vendors
5.2.4 DRO – Impact Analysis
5.2.5 Key Stakeholders
6 TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Single Intragastric Balloon
6.2.1 Overview
6.3 Dual Intragastric Balloon
6.3.1 Overview
6.4 Triple Intragastric Balloon
6.4.1 Overview
7 END USER: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Bariatric Surgical Centers
7.3 Ambulatory Surgical Care
7.4 Hospitals
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Market Overview
8.3 Europe
8.3.1 Market Overview
8.4 APAC
8.4.1 Market Overview
8.5 Rest of the World
8.5.1 Market Overview
9 COMPETITIVE LANDSCAPE
9.1 Overview
10 VENDOR PROFILES
10.1 Apollo Endosurgery, Inc.
10.1.1 Overview
10.1.2 Business Unit
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategy
10.2 OBALON THERAPEUTICS, INC.
10.2.1 Overview
10.2.2 Business Focus
10.2.3 SWOT Analysis
10.2.4 Business Strategy
10.3 Spatz FGIA, Inc.
10.3.1 Overview
10.4 ReShape Medical Inc.
10.4.1 Overview
Tables
Table 1 CATEGORIZATION OF INDIVIDUALS WITH BMI
Table 1 COMPARISON OF DIFFERENT BARIATRIC SURGERY COST IN DEVELOPED AND DEVELOPING NATIONS
Table 2 COMPARISON OF INTRAGASTRIC BALLOON PROCEDURE WITH AND WITHOUT INSURANCE IN 2016 ($)
Table 3 ALTERNATE TECHNIQUES FOR TREATMENT OF OBESITY
Table 4 GLOBAL INTRAGSTRIC BALLOON MARKET BY TYPES, 2016–2023 ($MILLION)
Table 5 GLOBAL INTRAGASTRIC BALLOON MARKET BY END-USERS
Table 6 GLOBAL INTRAGASTRIC BALLOON MARKET REVENUE BY REGIONS FORECAST, 2016–2023 ($MILLION)
Table 7 DRO (NORTH AMERICA)
Table 8 DRO (EUROPE)
Table 9 DRO (APAC)
Table 10 DRO (REST OF THE WORLD)
Table 11 APOLLO ENDOSURGERY, INC.: PRODUCT OFFERINGS
Table 12 APOLLO ENDOSURGERY, INC.: RECENT DEVELOPMENTS
Table 13 OBALON THERAPEUTICS, INC: RECENT DEVELOPMENTS
Charts
Chart 1 PERCENTAGE LOSS EXCESS WEIGHT LOSS FROM 3 MONTHS TO 1 YEAR
Chart 2 GLOBAL HEALTHCARE EXPENDITURE GDP AND PER-CAPITA SPENDING IN 2015
Chart 3 INTRAGASTRIC BALLOON DEVICES MARKET SEGMENTATION
Chart 4 RESEARCH METHODOLOGY OF GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 5 GLOBAL INTRAGASTRIC BALLOON BY SEGMENTATION, 2016 (% SHARE)
Chart 6 GLOBAL INTRAGATSRIC BALLOON MARKET SNAPSHOT 2016
Chart 7 GLOBAL INTRAGSTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 8 PEST ANALYSIS OF GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 9 PORTER 5 FORCES ON GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 10 GLOBAL INTRAGASTRIC BALLOON MARKET DYNAMIC -DRO
Chart 11 DRO – IMPACT ANALYSIS OF GLOBAL INTRAGASTRIC BALLOON MARKET
Chart 12 KEY STAKEHOLDERS
Chart 13 GLOBAL INTRAGASTRIC BALLOON MARKET BY TYPE SEGMENTATION, 2016 (% SHARE)
Chart 14 GLOBAL INTRAGASTRIC BALLOON MARKET BY TYPE SEGMENTATION, 2023 (% SHARE)
Chart 15 GLOBAL INTRAGASTRIC BALLOON MARKET OVERVIEW BY PRODUCT TYPE 2016
Chart 16 GLOBAL SINGLE INTRAGASTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 17 GLOBAL DUAL INTRAGASTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 18 GLOBAL TRIPLE INTRAGASTRIC BALLOON MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 19 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY PRODUCT TYPE, 2016-2023 ($MILLION)
Chart 20 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY PRODUCT TYPE, 2016-2023 (% SHARE)
Chart 21 GLOBAL INTRAGASTRIC BALLOON MARKET BY END-USER SEGMENTATION, 2016 (% SHARE)
Chart 22 GLOBAL INTRAGASTRIC BALLOON MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (% SHARE)
Chart 23 GLOBAL INTRAGASTRIC BALLOON MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (% SHARE)
Chart 24 GLOBAL INTRAGASTRIC BALLOON MARKET OVERVIEW BY REGIONS 2016 ($ MILLION)
Chart 25 INTRAGASTRIC BALLOON MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 26 INTRAGASTRIC BALLOON MARKET REVENUE IN THE EUROPE, 2016–2023 ($MILLION)
Chart 27 INTRAGASTRIC BALLOON MARKET REVENUE IN APAC, 2016–2023 ($MILLION)
Chart 28 INTRAGASTRIC BALLOON MARKET REVENUE IN THE REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 29 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 ($MILLION)
Chart 30 GLOBAL INTRAGASTRIC BALLOON MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 (% SHARE)
Chart 31 APOLLO ENDOSURGERY, INC.: OVERVIEW SNAPSHOT
Chart 32 APOLLO ENDOSURGERY, INC.: BUSINESS UNITS
Chart 33 APOLLO ENDOSURGERY, INC.: GEOGRAPHIC REVENUE
Chart 34 APOLLO ENDOSURGERY: SWOT ANALYSIS
Chart 35 OBALON THERAPEUTICS, INC.: OVERVIEW SNAPSHOT
Chart 36 OBALON THERAPEUTICS, INC.: SWOT ANALYSIS
Chart 37 SPATZ FGIA, INC.: OVERVIEW SNAPSHOT
Chart 38 RESHAPE MEDICAL INC.: OVERVIEW SNAPSHOT
